Biodesix Inc (BDSX) - News Archive

At the 2025 ASCO Annual Meeting, Biodesix announced significant discoveries from their INSIGHT study, emphasizing the predictive capabilities of the VeriStrat Host Immune Classifier (HIC) in assessing overall survival o...

Biodesix Announces New Data Presentation at CHEST 2024 Annual Meeting and the Launch of a Complementary Clinical Study In a bold maneuver that showcases its commitment to advancing lung disease diagnostics, Biodesix, In...

Biodesix, Inc. (Nasdaq: BDSX), a pioneering diagnostic solutions company specializing in lung disease, has recently announced ground-breaking new data that will be presented at the 2024 American Thoracic Society (ATS) I...

Biodesix Announces Impressive First Quarter 2024 Results Driven by Growth in Lung Diagnostic Testing for Lung Nodule ManagementLOUISVILLE, Colo. - Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostic solutions company sp...